| Date | Time | Source | Headline | Symbol | Company |
| 08/21/2008 | 11:08AM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 08/20/2008 | 4:40PM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc.- (25-NSE) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 08/20/2008 | 1:23PM | PR Newswire (US) | Lilly Announces Completion of SGX Acquisition | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 08/20/2008 | 12:58PM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Current report filing (8-K) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 08/18/2008 | 3:47PM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 08/14/2008 | 6:02AM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 08/13/2008 | 7:00PM | PR Newswire (US) | SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 08/13/2008 | 7:00AM | PR Newswire (US) | Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 08/08/2008 | 2:17PM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Current report filing (8-K) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 08/07/2008 | 5:05PM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Quarterly Report (10-Q) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 08/07/2008 | 6:00PM | PR Newswire (US) | SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 08/07/2008 | 4:54PM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 08/06/2008 | 1:01PM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 08/05/2008 | 6:00AM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 08/04/2008 | 8:00AM | PR Newswire (US) | Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 07/24/2008 | 11:20AM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Confidential Treatment Order (CT ORDER) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 07/21/2008 | 5:25PM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Proxy Statement - Merger or Acquistion (definitive) (DEFM14A) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 07/18/2008 | 3:41PM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Statement of Beneficial Ownership (SC 13D) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 07/16/2008 | 9:51AM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 07/14/2008 | 5:15PM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 07/11/2008 | 7:31PM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 07/10/2008 | 9:24AM | PR Newswire (US) | BeaconEquity.com Issues TraderNotes on Active Stocks: BSRC, DLLR, PGSI, BBND, SGXP, EXEL, OPWV, SCHW | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 07/10/2008 | 6:49AM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Proxy Statement - Merger or Acquistion (preliminary) (PREM14A) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 07/09/2008 | 6:03AM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 07/08/2008 | 4:52PM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Current report filing (8-K) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 07/08/2008 | 4:50PM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 07/08/2008 | 5:33PM | PR Newswire (US) | Lilly to Acquire SGX Pharmaceuticals | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 07/07/2008 | 5:22PM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 06/30/2008 | 7:00AM | PR Newswire (US) | SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393 | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |
| 06/23/2008 | 4:39PM | Edgar (US Regulatory) | Sgx Pharmaceuticals, Inc. - Statement of Beneficial Ownership (SC 13D) | NASDAQ:SGXP | Sgx Pharmaceuticals (MM) |